Cape Biologix Technologies develops and manufactures plant-made, recombinant monoclonal proteins.
We use our plants as single-use, biodegradable bioreactors to produce pharmaceutically relevant proteins for multiple uses across diagnostics, vaccines, or therapeutic applications.
As you might have noticed, we LOVE plants. We love them so much in fact that we're on a mission to use plant biotechnology to improve the well-being of people, animals, and plants đź’š
Feel free to reach out to us if you're like to connect.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 5 Sunrise Circle, Cape Bio Pharms,south Africa
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://capebiologix.com/
- Keywords
- delivery and economic growth..
- HQ
- Cape Town, Western Cape
Cape Biologix Questions
Cape Biologix's website is https://capebiologix.com/
Cape Biologix's LinkedIn profile is https://za.linkedin.com/company/cape-biologix-technologies
Cape Biologix has
12 employees.
View email and phone details for 12
employees at Cape Biologix.
Cape Biologix's industry is
Pharmaceutical Manufacturing
Cape Biologix's top competitors are
MĂ©rieux Nutrisciences - Global,
Separation Scientific (Sep Sci),
Biovac,
Michem Dynamics (Pty) Ltd,
Capebio,
Inqaba Biotec,
Assurecloud,
Uvu Bio,
Synexa Life Sciences,
Smt Labs.
Cape Biologix's categories are Pharmaceutical Manufacturing
Cape Biologix's founding year is 2020
